Product: NantHealth

Filter

Thought Leadership

Product

Community

3 Ways Healthcare Payers and Providers Are Adjusting to the New Normal Post-COVID-19
Over the last few months, COVID-19-related events have been a stress test for our entire healthcare ecosystem. And they continue...
NaviNet
Employee Spotlight: René Torres
René Torres began his “Nant journey” in 2013 as part of our parent organization’s Human Resource team. Currently, René serves...
NantHealth
NantHealth
NantHealth Announces Research Results that Advances Understanding of Tumor Treatment Resistance
Study Published in JCI Insight sheds light on the importance of using both transcriptomics and genomics for patient tumor interrogation...
NantHealth
NantHealth
NantHealth Presented Clinical Data on Immunotherapy, Molecularly Targeted Agents and Tumor Biology at the American Society of Clinical Oncology (ASCO)...
Findings presented during the developmental therapeutics session at the ASCO 2020 Virtual Scientific Program Culver City, CA – June 18,...
NantHealth
NantHealth
NantHealth to Exhibit at Virtual America’s Health Insurance Plans (AHIP) Institute & Expo 2020 with Webinars to Follow
NantHealth Announces Eviti Product Updates to Aid Efficiency and Reporting for Payers & NaviNet Product Updates to Enhance the User...
NantHealth
The Science Behind Emerging Treatments COVID-19 Webinar: Your Questions Answered
NantHealth recently hosted a webinar entitled “The Science Behind Emerging Treatments: A COVID-19 Discussion,” with NantHealth Chief Medical Officer, Dr....
NantHealth
AHIP Institute & Expo Online 2020
A Conference Built to Match the Moment: Join thousands from around the country and virtually engage with leading experts as...
NantHealth
Pushing Left: What Software Engineering Can Teach Healthcare
For years, we in the software business have worked to create leaner, more efficient processes by pushing decision-making “left” into...
NantHealth
Live Webinar: The Science Behind the Emerging Treatments—A COVID-19 Discussion
Thursday, May 14 at 12 pm ET NantHealth hosted a live webinar moderated by our Chief Medical Officer, Sandeep ‘Bobby’...
NantHealth
NantHealth
NantHealth Reports 2020 First Quarter Financial Results
Q1 Financial Highlights 2020 vs 2019: SaaS revenue was $18.1 million, up 2% Total gross margin increased to 60% from...
NantHealth
COVID-19 and the Question of Hydroxychloroquine Safety & Efficacy
Today’s blog is about N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine (say that five times really fast!), better known as hydroxychloroquine (HCQ), a drug to treat...
NantHealth
NantHealth
NantHealth to Report 2020 First-quarter Financial Results and Host Conference Call on Thursday, May 7
CULVER CITY, Calif.–(BUSINESS WIRE)–May 4, 2020– NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report...
NantHealth